Reply: Lysosomal dysfunction in Parkinson's disease

Affiliations

¹ 1 Neuroscience Research Australia, Sydney, NSW 2031, Australia 2 School of Medical Sciences, Faculty of Medicine, The University of New South Wales, Sydney, NSW 2052, Australia g.halliday@neura.edu.au.
² 1 Neuroscience Research Australia, Sydney, NSW 2031, Australia 2 School of Medical Sciences, Faculty of Medicine, The University of New South Wales, Sydney, NSW 2052, Australia.

Comment

Glenda M Halliday et al. Brain. 2015 Apr.

. 2015 Apr;138(Pt 4):e340.

doi: 10.1093/brain/awu268. Epub 2014 Sep 11.

¹ 1 Neuroscience Research Australia, Sydney, NSW 2031, Australia 2 School of Medical Sciences, Faculty of Medicine, The University of New South Wales, Sydney, NSW 2052, Australia g.halliday@neura.edu.au.
² 1 Neuroscience Research Australia, Sydney, NSW 2031, Australia 2 School of Medical Sciences, Faculty of Medicine, The University of New South Wales, Sydney, NSW 2052, Australia.

No abstract available

Comment on

Reduced glucocerebrosidase is associated with increased α-synuclein in sporadic Parkinson's disease.
Murphy KE, Gysbers AM, Abbott SK, Tayebi N, Kim WS, Sidransky E, Cooper A, Garner B, Halliday GM. Murphy KE, et al. Brain. 2014 Mar;137(Pt 3):834-48. doi: 10.1093/brain/awt367. Epub 2014 Jan 28. Brain. 2014. PMID: 24477431 Free PMC article.
Lysosomal dysfunction in Parkinson's disease.
McNeill A. McNeill A. Brain. 2015 Apr;138(Pt 4):e339. doi: 10.1093/brain/awu266. Epub 2014 Sep 11. Brain. 2015. PMID: 25212849 No abstract available.